LEPR and cancer: In addition, leptin receptor is relatively high expressed in kidney cancer, liver cancer, lung cancer, mesothelioma, ovarian cancer, pancreatic cancer, prostate cancer, sarcoma, thyroid cancer and acute myeloid leukemia, indicating the potential pathological role of this axis in cancers.